DISEASE INDICATIONS:Psoriasis

MANUFACTURER:Eli Lilly Nederland B.V.

USAGE:Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Taltz (ixekizumab) is a medication used to treat moderate-to-severe plaque psoriasis, active psoriatic arthritis, and active ankylosing spondylitis.